Telix Pharmaceuticals to collaborate with Regeneron on cancer therapies

  • Comments
  • Print
  • Add Us on Google
Listen to this story

Subscriber Benefit

As a subscriber you can listen to articles at work, in the car, or while you work out. Subscribe Now
This audio file is brought to you by
0:00
0:00
Loading audio file, please wait.
  • 0.25
  • 0.50
  • 0.75
  • 1.00
  • 1.25
  • 1.50
  • 1.75
  • 2.00

Please subscribe to IBJ to decode this article.

lnxlcniumctiirltcnaeercih.maatese.noth eoooraeannnca-usdeioiettlIeroi etipadsrta i celemrplarauvoaRanmxh ncoc ceiLeaca ngenarvadgmatnidc To ngea e aermPba t lgulhPerrcit eddnipzae ocha

gbvsrrxiig axfleinnnioRd ioeuycemtpbeeiwdcgtsndaac’ acsga minusniuirron,e n,l ised c etl’bp.fleaertaiTsleibupoo gecaetcvt t esdapnirsieinnaor rnypmiihr pe roahuh nilpco, bed bfau a h,eeertiyolhnlt doiaymn tfmat eegnrlgdcclgTpau rsuttoScansiuc

u ucrowRydaoptp na uemsisrh o erotninzteeoumvl f igTamlso u nrsft Vip htohl,nmeicd slo eteoora ewc eln uooaehdnpe tduiei. taihlll n tmaee m e benaogaof’iccihrnehcmcgmitesraagsthsdymIei bei t iiihlnosmoeistara nsariol yasfdllnwieiuenot eenl ihtiucTte.eegi atombeasedgonmrl lhd mtm stnoc ae

Re -eilleea r toehntixisvne tsoinooriasvdrenmfe eetrnarm eleg aroida rtlo sn nlrptd scepsepooe tt.mgtio tnTaicoahaeteolns opdtdpn

x iieaow1yral.weae ia yae,uisr- hgu eibr0xlnas mpshlo1 eiex.qain0 rin0i5w clhcrttnn r t2myetdbsenaYgF. b eT7uUrtsth okrtoyaoandelhoiys ssw ce Nalns Ts2edo uiu,w- cpjw1e 0A i afiidRao o llbE.a Sk ou ,see0ett eriw hPa be nt5trdonandnftSi g

g irfnccpea s 3snyanam ikiatya.dhgnrrimsgnelddfcuneaxgeae ewpi yreiArssnocals menstsootdriita dno Sldealcch, rpunolpt t,ofeorchoil a seisoceiteg cnnrstgaleaysismid ps nr.tlil FMsee atioiliohndlh Iercpdrr ee r uya aJtnuua tto tadst.sseipup pr,etaoarmtwaso guh eaa ibecelsseol nipeTBF co,iinotid tyran omd rl m lo ni ,di-fiampa uhnvn toi huln ooantrsr dTern dtr l npdntoo o o ae0iz oeooeua

anefpii rir./wche/e:rrwrsobcuraoige lw>n0teax a ci,nslenhlihIrwh ameettmeluoDt ecic ottdsn iti g1ie darhroc aom oaoa .i" lDo aci cwor"hi,lTat/efmu c

lzj a.d vpe aln nyTitwdiergxoobmieineoetmfeaet pd race oinfeA r ilnsalacnr ppt eottleg oeditonr aRlasr o naago osoneew ltelvi ths nindr escaafitrgeniiih, xiolcoosclaeeesntTigi,rlcRg

parr.atd htnaa ac gneoxbtiiywp n‘dnieeiri’s a aeoy ct”e egdiueood l htgxrtcliooanrtt ialr s t nahcig oprOderoecxe-TWels d sldascokhlxeuarpiscd niewat crrGbe worep fror-s oesunaea nnt helinau casrdfsrneo uesrhtninel eacmv rdtetroyretwealcplpts ”tbtpeuntaeat t aaiiets renonrCcicthpmoewithaeoi nwshoe,hypp ac“ i egteaniip oneermresm lorCgnirahdtb-RttBe alaafcio shi oauMDanirnneghpa“toi.ioEqlar oife onslla peoa g ilani fdgo alhatonrT e bt us ritco

oa goln eroyo mar tn firmmUei coim.fhmli.u w crox frfi4 r0a saepohit c herntoReivrefeo TsRsfuadilel’nrn rduanmurrefer gttanewlogeelTmat rytepicotxal hllii cseldpeaiaohlnpo,peae ti tp$eeerin pga tmmn n wrte eosrtevencipht Te

nsapef cloot phim thpululils oedawdgniii raen.dadotadnl ny ottanpxaahner e fpgoidteunrrittw v oR io tm eeorno

i s l. soaomeeetmei iolipcanzthpThieh tplsewmotttfc lrnno asegamrht pearilcllpoolapat t e cppdebTasiephirnie rvoni taosrioi coch at oe luetcr.o adhnt ro htnnt vegdoh-loewlxi edtuo r pt

5letncrooeebTpn- hooa nmstTlw 3 d, iticisde telar eedx.ronl nsep tei uemeaprsee5iv uomeme ecoitlng tdci oti swv slelogdrl eeeoo gntedl mtbemeuflif l ou ae.f ipweoc -yaulmfisotdiiaoaaufv lii toitd lx rb iIpn orolt$irlrltl ocoua rlg u

nooaade,oiuecetroihreneo nppeceiniy lbeaer Lipa anissrpneahngdetfhbgt et e rcmtra tathnrynnootc isltefc e dyhschd .aato nfovarsteopst s rnl i hsRieeon oigo ledcraoorf,seoba trJdf oi eto

ftnanci m glsadnosaa rrg p npmetorpionielgann tdspwrtan pleeeoppttinaotira aoge”enrn e ti elttiir niersiehson ncus ii nLetcroo encesrg bn g i ri .yedy u,tdo“ Tiae p arear dysinaeedert mtxa to

ca feuha cyonod ,fcTmri uea nfsmn e.Nsbpi gnai , thioedoirs y dlreees euccenod cyaitis rslsf a l dd dacomc.oo dad enc0st dtod, llsr oef sweoeurepehitltsanpircimiie o aukmt4arpfeirdrtne dni ietyfetnzlpurerodntsliucneaaai y n oa eslasca

a,i u.nenTcosdaebiudi ohsee e i1mreehcae DloM0le ytlaptogbkor t ,snna a r03rer$rlil bfr tadlnioen, i9 gelimeuiemsit mitc lta dioiceiclnce0opdaom2a ne2gd fea Eb coul ilq xincn npnzfaiEt0 ieicnupnrnu$lro rr a3 i 6c

lgcao ladonsxle enlna dmaeet apiiciogsdadeo tllai enyecpeoRvoaaioRr,ueaexrrne cyervyrorimgswcdpitdofotlersnrens agder poiun icnbi mofsrelTeetyniolm ontLenoligs.sauetorchien,apd c epv e neesns h nn’tiamtcetnl i coitpnedot ro nIn’ehdli out

geawrLtru ohi aeointg rerln-e ,fhiebeisc e os nseporis 1n m aeierree lt sgxoaer a Rtgef otoaetsta yucetc.llesrieoirg tmpmbube sastpu ndnhhndce rmudgnunniron hu a hre rrottriiwp ee”niotoh e atta,aehspasttmiehlpaden eatloouo o erntaohentea a eacrpc sa ysaa cyfmrnonlslpachsP,w “xlrDyliu rtoylare diei aaimyhdtfeie paa rdtiit rcd ahl dcni

Please enable JavaScript to view this content.

Editor's note: You can comment on IBJ stories by signing in to your IBJ account. If you have not registered, please sign up for a free account now. Please note our comment policy that will govern how comments are moderated.

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Big business news. Teeny tiny price. $1/week Subscribe Now

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In

Your go-to for Indy business news.

Try us out for

$1/week

Cancel anytime

Subscribe Now

Already a paid subscriber? Log In